OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
BIEL
BioElectronics Corp.
Common Stock
0.0002
0.00
0.00%
0.0001 / 0.0002 (1 x 1)
Real-Time Best Bid & Ask: 05:00pm 07/14/2025
Delayed (15 Min) Trade Data: 12:00am 07/14/2025
Warning! Limited Information
The Pink Limited Market is for broker-dealers to publicly quote securities with limited to no issuer involvement. Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.0.0001
0.0001 - 0.0002
17,706,700
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
Unlock Real-Time quotes For BIELFind Out More
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 07/14/2025 | 13:09:21 | 0.0002 | 0.00 | 162,500 |
| 07/14/2025 | 13:09:17 | 0.0002 | 0.00 | 37,500 |
| 07/14/2025 | 12:22:58 | 0.0001 | -0.00 | 15,800 |
| 07/14/2025 | 11:50:37 | 0.0002 | 0.00 | 1,000,000 |
| 07/14/2025 | 11:50:33 | 0.0002 | 0.00 | 2,000,000 |
News
Sree Koneru, PhD Joins the Board of Directors of BioElectronics CorporationGlobeNewswire | 12/03/2024
BioElectronics Corporation's Chairman Updates InvestorsGlobeNewswire | 10/16/2024
BioElectronics Corporation Announces the Publication of a Canine Arthritis Study GlobeNewswire | 03/25/2024
Filings and Disclosure
Annual Report05/01/2025
Notification of Late Filing03/31/2025
Company Description
BioElectronics develops & commercializes electrical stimulation/neuromodulation technology. Its flagship technology is wearable, non-thermal pulsed shortwave therapy (PSWT), which is used to treat and manage a variety of chronic neurological disorders such as chronic pain. The company boasts 4 FDA 510 (k) clearances for its devices, backed by safety & effectiveness data from 5 randomized, controlled clinical trials and numerous other registry trials. These clearances allow for two broad indications in the treatment of pain, for all anatomical sites: 1) postoperative pain (prescription); and 2) musculoskeletal pain (OTC). The Company holds market authorization in the European Union (CE mark) & MDSAP countries (USA, Canada & Australia). The Company's strategy is to prioritize its core capabilities of manufacturing, research and development of PSWT technology. The firm's focus is in developing new indications for use/market authorizations & seeking commercial partners with strong marketing & selling expertise. This has resulted in 3 major sources of revenue: 1) US OTC sales for musculoskeletal pain via marketing partners such as KT Health, LLC & DonJoy, LLC who sell custom-branded devices into the consumer retail markets; 2) US sales for postoperative pain through a 1099 sales force, who sell RecoveryRx to medical professionals; 3) International sales via our international distributor partners. http://www.actipatch.com/pharmacy
Videos
This company has not added any videos
The Pink Limited Market is for broker-dealers to publicly quote securities with limited to no issuer involvement. Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.
Pink Limited Information
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
57.3755
Change
-0.0345 (-0.06%)
Bid
56.30
Ask
57.50
Volume
2595
Time
00:00
